Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Anca Askanase, MD, MPH

Director
Columbia University Medical Center
New York, NY, United States

Academic rheumatologist

Presentation(s):

  • Can Current Lupus Treatments Be Classified as DMALDs?

    Sunday, November 12, 2023
    9:30 AM – 9:45 AM PT

    Disclosure(s): Amgen: Data Safety Monitoring Board (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Clinical Trial Steering Committee (Ongoing); Genentech: Investigator in clinical trail (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Idorsia: Lead PI for clinical trial (Ongoing); Sanofi: Lead PI clinical trial (Ongoing)

  • 0608: Efficacy of Cenerimod in Patients with High IFN-1 Gene Expression Signature and High Anti-dsDNA Antibody Levels: Post-hoc Analysis from a Phase 2 Study

    Sunday, November 12, 2023
    9:00 AM – 11:00 AM PT

    Disclosure(s): Amgen: Data Safety Monitoring Board (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Clinical Trial Steering Committee (Ongoing); Genentech: Investigator in clinical trail (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Idorsia: Lead PI for clinical trial (Ongoing); Sanofi: Lead PI clinical trial (Ongoing)

  • 2332: Dapirolizumab Pegol Efficacy by Subgroups in Patients with SLE: A Post Hoc Analysis of Phase 2b Clinical Trial Data

    Tuesday, November 14, 2023
    9:00 AM – 11:00 AM PT

    Disclosure(s): Amgen: Data Safety Monitoring Board (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Clinical Trial Steering Committee (Ongoing); Genentech: Investigator in clinical trail (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Idorsia: Lead PI for clinical trial (Ongoing); Sanofi: Lead PI clinical trial (Ongoing)

  • 14T146: TeleRheumatology Research: Where We Are Today?

    Tuesday, November 14, 2023
    2:00 PM – 3:00 PM PT

    Disclosure(s): Amgen: Data Safety Monitoring Board (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Clinical Trial Steering Committee (Ongoing); Genentech: Investigator in clinical trail (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Idorsia: Lead PI for clinical trial (Ongoing); Sanofi: Lead PI clinical trial (Ongoing)